RVPH
Price
$0.82
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Capitalization
38.31M
9 days until earnings call
TCRT
Price
$2.85
Change
-$0.16 (-5.32%)
Updated
May 9 closing price
Capitalization
4.67M
Ad is loading...

RVPH vs TCRT

Header iconRVPH vs TCRT Comparison
Open Charts RVPH vs TCRTBanner chart's image
Reviva Pharmaceuticals Holdings
Price$0.82
Change-$0.00 (-0.00%)
Volume$267.67K
Capitalization38.31M
Alaunos Therapeutics
Price$2.85
Change-$0.16 (-5.32%)
Volume$15.73K
Capitalization4.67M
RVPH vs TCRT Comparison Chart
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVPH vs. TCRT commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a Hold and TCRT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (RVPH: $0.82 vs. TCRT: $2.85)
Brand notoriety: RVPH and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 39% vs. TCRT: 2%
Market capitalization -- RVPH: $38.31M vs. TCRT: $4.67M
RVPH [@Biotechnology] is valued at $38.31M. TCRT’s [@Biotechnology] market capitalization is $4.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileTCRT’s FA Score has 0 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • TCRT’s FA Score: 0 green, 5 red.
According to our system of comparison, RVPH is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 4 TA indicator(s) are bullish while TCRT’s TA Score has 4 bullish TA indicator(s).

  • RVPH’s TA Score: 4 bullish, 4 bearish.
  • TCRT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RVPH and TCRT are a good buy in the short-term.

Price Growth

RVPH (@Biotechnology) experienced а -5.44% price change this week, while TCRT (@Biotechnology) price change was +12.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

RVPH is expected to report earnings on Aug 18, 2025.

TCRT is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($38.3M) has a higher market cap than TCRT($4.67M). TCRT YTD gains are higher at: 49.606 vs. RVPH (-54.713). TCRT has higher annual earnings (EBITDA): -11.54M vs. RVPH (-33.27M). RVPH has more cash in the bank: 5.56M vs. TCRT (1.68M). TCRT has less debt than RVPH: TCRT (0) vs RVPH (83K). TCRT has higher revenues than RVPH: TCRT (7K) vs RVPH (0).
RVPHTCRTRVPH / TCRT
Capitalization38.3M4.67M820%
EBITDA-33.27M-11.54M288%
Gain YTD-54.71349.606-110%
P/E RatioN/AN/A-
Revenue07K-
Total Cash5.56M1.68M330%
Total Debt83K0-
FUNDAMENTALS RATINGS
RVPH vs TCRT: Fundamental Ratings
RVPH
TCRT
OUTLOOK RATING
1..100
1324
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5837
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCRT's Valuation (74) in the Biotechnology industry is in the same range as RVPH (93) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's SMR Rating (99) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's Price Growth Rating (37) in the Biotechnology industry is in the same range as RVPH (58) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (11) in the null industry is significantly better than the same rating for TCRT (100) in the Biotechnology industry. This means that RVPH’s stock grew significantly faster than TCRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVPHTCRT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

RVPH and

Correlation & Price change

A.I.dvisor tells us that RVPH and GYRE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+0.27%
GYRE - RVPH
31%
Poorly correlated
+0.53%
CLDX - RVPH
27%
Poorly correlated
-6.10%
XENE - RVPH
27%
Poorly correlated
-1.46%
INM - RVPH
25%
Poorly correlated
+1.96%
AFMD - RVPH
25%
Poorly correlated
-2.14%
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with GLTO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
-5.32%
GLTO - TCRT
56%
Loosely correlated
-3.35%
DSGN - TCRT
56%
Loosely correlated
-0.57%
BTAI - TCRT
26%
Poorly correlated
-3.16%
ADAP - TCRT
25%
Poorly correlated
-2.47%
RVPH - TCRT
25%
Poorly correlated
+0.27%
More